ABOS
Acumen Pharmaceuticals Accelerates Momentum in Quest to Revolutionize Alzheimer's Treatment
Acumen Pharmaceuticals, a pioneering force in the field of Alzheimer's disease treatment, has made significant strides in its pursuit of developing novel therapies for this debilitating condition. As highlighted during their recent second-quarter conference call, the company continues to advance its lead candidate, sabirnetug, towards a highly anticipated